Form 4: NeueHealth CEO George Lawrence Mikan III Reports Stock Transaction
SEC Form 4 Filing
George Lawrence Mikan III, CEO and President of NeueHealth, Inc., reported the vesting of restricted stock units on March 6, 2024.
Summary
- On March 6, 2024, George Lawrence Mikan III, CEO and President of NeueHealth, Inc., reported a transaction involving restricted stock units.
- 58,877 restricted stock units vested, each representing a contingent right to receive one share of NeueHealth's common stock.
- These restricted stock units vest in three equal annual installments beginning on March 6, 2024.
- Following the transaction, Mikan directly owns 88,804 shares of common stock and 117,753 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to executive compensation, and does not contain any information that would significantly impact investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Date of transaction: vesting of restricted stock units. |
| 03/06/2024 | First vesting date of the restricted stock units in three equal annual installments. |
| 03/08/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.